Levocabastine
General information:
| Withdrawn ID: | 698 |
|---|---|
| Canonical SMILES: | |
| Standard InChI: | |
| Standard InChIKey: | |
| ATC class(es): | R01AC02 |
| S01GX02 | |
| Molecular Formula: | C26H29FN2O2 |
| Molweight: | 420.528 |
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
|---|---|
| First approved: | 1993 |
Side-effects:
| Total reported cases (submitted by medical professionals) with Levocabastine as primary suspect: | 2 |
|---|
Reported final outcomes:
Reported side-effects:
| Side-effect | Case number |
|---|---|
| WRONG TECHNIQUE IN DRUG USAGE PROCESS | 1 |
| TREATMENT FAILURE | 1 |
| SWELLING FACE | 1 |
| RASH GENERALISED | 1 |
| RASH | 1 |
| OBSTRUCTIVE AIRWAYS DISORDER | 1 |
| HYPERSENSITIVITY | 1 |
| HYPERAEMIA | 1 |
| FOREIGN BODY SENSATION IN EYES | 1 |
| EYELID OEDEMA | 1 |
| EYE PRURITUS | 1 |
| DRUG ERUPTION | 1 |
Toxicity information:
| Toxicity class: | 4 |
|---|---|
| Toxicity type: | N/A |
| LD50: | 1354.5 mg/kg |
External links:
| ChEBML: | CHEMBL1615438 |
|---|---|
| DrugBank: | DB01106 |